Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
03.05.2010-25.05.2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Ashes (residues), vanadium-contg.
EC Number:
282-208-3
EC Name:
Ashes (residues), vanadium-contg.
Cas Number:
84144-87-6
Molecular formula:
Not available
Constituent 2
Reference substance name:
vanadium concentrate
IUPAC Name:
vanadium concentrate
Details on test material:
- Name of test material (as cited in study report): vanadium concentrate
- Lot/batch No.: 14-45810
- Preperation date: 07/2009
- Expiry date: 30. Sept. 2011

Method

Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Details on mammalian cell type (if applicable):
no data
Additional strain / cell type characteristics:
not specified
Species / strain / cell type:
E. coli WP2 uvr A pKM 101
Details on mammalian cell type (if applicable):
no data
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
2-Aminoantracene, Benzo(a)pyrene
Test concentrations with justification for top dose:
Sample was analyzed at these concentrations: 5, 1.6, 0.5, 0.16, 0.05 mg/plate

Vehicle / solvent:
Water: Recently distilled, not demineralised and sterilized in autoclave Water without bacteria toxic or inhibitory substances.
Controls
Untreated negative controls:
yes
Remarks:
100 µL of distilled sterile water
Negative solvent / vehicle controls:
yes
Remarks:
water
True negative controls:
no
Positive controls:
yes
Remarks:
100 µL of the positive controls solution, specific for each strain
Positive control substance:
other: Sodium azide (CAS: 26628-22-8), 2-Nitrofluorene (CAS: 607-57-8), 9-Aminoacridine hydrochloride hydrate (CAS: 52417-22-8), N-Nitroquinoline-1-oxide (CAS: 56-57-5), 2-AminoAntracene (CAS: 613-13-8), Benzo(a)pyrene (CAS: 8165 BP)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Preincubation period: none
- Exposure duration: 72 h at 37 °C on a Vogel Bonner plate after adding 100 µL of working solution (and S9 mix for the metabolic activation test)

SELECTION AGENT (mutation assays): UV for uvrA/B mutation; crystal violet for rfa mutation and ampicillin for R factor plasmid

NUMBER OF REPLICATIONS:
without metabolic activation system: test was carried out in triplicates for negative control, positive control and test substance
with metabolic activation system: test was carried out in triplicate for the negative control and in duplicates for the positive control and test substance
Evaluation criteria:
CRITERIA FOR A POSITIVE RESPONSE IN TESTER STRAINS
Tester Strains TA98, TA 100 and WP2uvrA
The test substance is considered positive when, in at least one of these tester strains, it produces at least a 2-fold rise of the increase value over the increase value in the appropriate vehicle control (see tables 2-6). This rise in the increase value must be accompanied by a positive Dunnet’s test (alpha = 0.05 1-sided) and a dose response when the concentrations of the test substance is increased.

Tester Strains TA1535, TA1537
The test substance is considered positive when, in at least one of these tester strains, it produces at least a 3-fold rise of the increase value over the increase value in the appropriate vehicle control (see tables 2-6). This rise in the increase value must be accompanied by a positive Dunnet’s test (alpha = 0.05 1-sided) and a dose response when the concentrations of the test substance is increased.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A pKM 101
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
not valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

In this study the test substance does not induce significative point mutations.
Executive summary:

In a reverse gene mutation assay in bacteria, four strains of S. typhimurium (TA98, TA100, TA1535, TA1537) and one strain of E. coli (WP2 uvrA pKM101) were exposed to Vanadium concentrate at concentrations of 5, 1.6, 0.5, 0.16, 0.05 mg/plate in the presence and absence of mammalian metabolic activation

 

Vanadium concentrate was tested up to the limit concentration (5 mg/plate). The positive controls induced the appropriate responses in the corresponding strains.  There was no evidence or a concentration related positive response of induced mutant colonies over background.

 

This study is classified as acceptable.  This study satisfies the requirement of OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation).